Sep 2026· European journal of pharmaceutics and biopharmaceutics· pp.
115243
· 0 citations· 140 references
Medicine
Abstract
Andrographolide (AG) has been reported for its anticancer activity. However, it is classified as a class IV in the biopharmaceutics classification system (BCS). Therefore, AG possesses low bioavailability due to its low solubility and permeability. In this study, hyaluronic acid-coated chitosan nanoparticles (Hyalo-CS-NPs) were formulated to enhance AG delivery and allow the active targeting of CD44 receptors overexpressed on breast cancer cells. Results showed optimized AG-Hyalo-CS-NPs with a size of 388.2 ± 1.41 nm, a zeta potential of -25.7 ± 1.58 mV, and an entrapment efficiency of 95.3%±1.01%. In vitro release profile revealed a sustained pH-responsive release from coated and uncoated CS-NPs with greater AG release under acidic conditions that mimic the tumor microenvironment. The MTT assay demonstrated the sharpest decline in the MCF-7 cell viability. Moreover, flow cytometry studies illustrated a significant apoptosis compared to uncoated nanoparticles and AG suspension. In addition, biochemical marker evaluation showed upregulating of the pro-apoptotic protein Bax and downregulating of Bcl-2, HER2, and Cyclin D1, confirming the underlying mechanism of the anticancer activity. Finally, confocal imaging showed higher intracellular uptake from coated and uncoated CS-NPs by 2.2-fold and 1.85-fold, respectively. In conclusion, AG-Hyalo-CS-NPs is a smart, targeted nanoplatform that improves AG anticancer efficacy in breast cancer management.
Findings highlight the potential of celecoxib-loaded Soluplus/zein nanoparticles coated with chitosan as a promising pulmonary drug delivery system for NSCLC via nebulization via nebulization.
Khin Cho Nyein, Maxius Gunawan, Papon Muangsanit et al.· ACS Omega· 0 citations
CCIPLUTLNPs represent a promising multifunctional nanoplatform that integrates efficient drug delivery, ROS-mediated PDT, and multitarget molecular interactions, offering a potential strategy for improved PCA treatment.
Riyad F. Alzhrani, Khalid A. Alamer, Nasser Alothaymin et al.· International Journal of Mol...· 0 citations
Improved cellular uptake and greater drug accumulation inside cells led to improved apoptotic activity and thus, more clonogenic activity and thus, more clonogenic activity, suggesting that SLNs-based nanoencapsulation is a promising approach for enhancing the therapeutic efficacy and safety of COR for breast cancer th...
Saumyadeep Bora, Ravi Amirthalingam, Bhavana Jodha et al.· Medical Oncology· 0 citations
Glioblastoma (GBM) remains a highly aggressive brain malignancy with limited therapeutic success owing to poor drug accumulation and restricted brain delivery. Dasatinib (DTB), a tyrosine kinase inhibitor with anticancer potential, is limited by poor solubility and brain penetration. This study developed l-arginine-gra...
Mansi Thakur, Aditi Sonone, Sagar S. Trivedi et al.· Nanomedicine: Nanotechnology...· 0 citations
Related blog posts
MIT News · Artificial Intelligence· news.mit.eduNov 9, 2026
A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.